BioWorld Asia

Dec. 17, 2003

View Archived Issues

Acambis Files 'First-Ever' BLA: Arilvax Vaccine In Yellow Fever

Acambis plc filed a biologics license application seeking approval of Arilvax as a vaccine to prevent yellow fever. (BioWorld International) Read More

Arpida Moving Iclaprim Into Phase III Trial, Seeking EUR25M

Read More

Trial To Test Recombinant Poxvirus Vaccine In Malaria

Read More

Genmab Stops HuMax-CD4 Development In Psoriasis

Read More

Ingenium Plans Growth After Third Round Brings In EUR13.8M

Read More

Benitec Settles ddRNAi Dispute, Raises A$10.9M To Fund Growth

Read More

Faust Pharmaceuticals Acquires Euroclide, Seeks EUR12M Funding

Read More

Innate Pharma, Novo Nordisk In Cancer Immunotherapy Deal

Read More

Novacea Licenses Cancer Drug From KuDOS Pharmaceuticals

Read More

London Cluster Growing But Lab Space Shortage Impedes

Read More

EU Moving Closer To New Rules On Pharmaceuticals, Tissues, Cells

Read More

Industry Representatives Meet In Israel To Discuss Bioengineering

Read More

Fulcrum To Help Addex Build Internal Clinical Development

Read More

Other News To Note

Read More